of drugs though the semipermeable round window membrane. The round window is permeable 10 various medications. which include gentamicin for the treatment of Meni~re's diseuse (1) (2) (3) (4) and prednisolone for idio· patllie sensorineural heari ng loss (5-7 J. The put.:ntial b.:netits of round window delivery of drugs include a low systemic ahsorption and toxicity and the easc of delivery in th~ outpatient setling.
Teehniqu~s d~veloped for round window drug de· livery have included blind transtympanic injections (l,2) . gelfoam (8) . elvax-impregllated discs (9) , transtympanie Addr'" correspondence ~nd reprint reque~'s to Stephen O·Lea!)'. lIniver"ily "f Melbourne. Dcpnnmenl of OlOlaryngology. 32 Gi5bome St. East Melbourne. VIC 3()(J2. Aw,tralia; E-nMil: sJoleary (~'uni",c1b. cdu,au
Fundin~ for this study was supplied by Royal Au,trnlasian College of Surgeons "nu 'he Stavros S. Niarcho' Foundation. microcatheters (3, 4) . and the microwick made of polyvinyl (10) . However. many of the methods inves tigated so far have limitations. Transtympanie delivery is limited by poor targeting and uncontrolled dose delivery. With the exception of gelfoam. most of the delivery ~ystem.~ are not biodegradable. Pump systems ,Ire limited by their cost and the requirement for hospitalization.
'. Direct intraeochlear deli\ery of drugs by way of pumps an: an established experimental tool (I 1-15) . but these systems are not suitable for human usc because of the risk of introducing infection into the inner ear and the putenti,t1 sequelae of meningitis. We report a novel system for the deli\ery of drugs to the inner ear using a hiodegradable and relatively inert agent, alginate-heparin beads. This system facilitates controlled and sustained drug delivery. Alginate as a delivery vehicle has been succe.~sfl111y llsed to encapsu late and deliver diverse bioactive growth factors (16) sueh as basic fibroblast ,growth factor (17,18), leukemia inhibitory factor (19) . nen'e growth fnctor (20) . and ciliary neurotrophic factor (21) . FurthemlOJ'e, alginate has also been demonstrated to b~ an adequate nerve and cellular growth matrix (22) (23) (24) . Heporin was also investigated as a suitable additive to our delivery system as a modulator for release of growth factors. Heparin has been used to modulate release of growth factors such as basic fibroblast growth factor, nerve growth factor, neurotrophin (NT)-3, and brain derived neurotrophic foctor from fabricated matrices in a slow amI controlled manner (17, 18, (25) (26) (27) ,
In this study, we investigated the ertkacy of NT-3 release from alginate·heparin beads implanted on to the round window of guinea-pig cochleae. Auditory neurons degenerate and significant numbers undergo apoptosis after any cochleor pathology, resulting in the loss of hair cells. which includes most types of sensorineural hearing loss and ototoxic injul·ies. NTs have been shown to promote the survival of the auditory nerve in vitro (28-35) and in vivo (13.36.37) . Because the optimal functioning of cochlear implants requires the preserva tion of this population of auditory neurons, there is interest in the potential therapeutic use of ~Ts, such as NT-3, as an adjunct to implantation. For this reason, we , il1\~stigated the round window delivery of NTs because this could potentially preserve the auditory neural 'population after deafness has occurred but before cochlear implantation. Another potential therapeutic role for NT-3 is the prevention of ongoing apoptosis of auditory neurons after cochlear implantation. This could bc achieved by the slow intracochlear release of NT-3 from polymers coating the cochlear electrode. These electrodes are implanted into the basal turn of the cochlea (in a Nuid filled chamber known as the scala tympani). To determine whether this may be feasible, \\e also il1\'es ligated whether ,dginme beads introduced into the scala tympani were effective in preventing degeneration of the auditory nerve.
I\IATERIALS AND METHODS

Alginate Bead Production
Aiginat~ beads were prepared using an ionic gelation technique, Two percent (w/v) sodium alginate (KcIHV; ISP. Sih erwmer. l'\S\\'. Australia) with or without J<,} (w/v) heparin (Si"rna·Aldrich. Castle Ifill. NSW. Australia) was dissol\ed in l\lilliQ water and mixed overnight until dissol\'cd fomling a ~el-like solution. Subsequently. Ihe gel was extruded through a -'O·gauge needle into a bath of 0, I !VI CaCI~. precipitating cakiU/ll alginate spheres. The be"d, were all<med to mature with gentle stirring for 20 mintiles "nd then washed three times over 30 to 40 minutes with 0.9% (w/v) N"CI. This method produced large beads in the order of 2 to 2.5 mm. For in \ ivo experiments, u stre;lm of high-pressure CO! was passed through the needle as the gel was extruded, precipitatlllg smaller (05-1 mm) alginate-heparin beads. The heads were produced using sterile solutions and equipment in a larnin~r now hood and finally ultra\'iolet irradiated for 30 minutc>. All beads were nl~de fresh for in vivo experimellls with a to ["1 dose of approximately 1.5 ~g of NT-3 for each "loaded bead" cxperiment (3).
In Vitro NT-3 Release Studies Algin"te and alginate-heparin beads were tested for loading and release of NT-3 in vitro using an enzyme-linked im· rnunosorbent assay (ELISA). The aim was to produce the most effective loading ami release profile for alII' delivery system. Beads with diameters of 2 to 2,5 mm were loaded with human recombinant NT-3 (Chemicon, Boronia. Vic. Austr~lia) by incubating the beads overnight at 37 c C in Ringer's solution eonluining NT·3. Uptake of :"T-3 was quantified by measuring the diirerences between the initial and leftover loading solutions by a cOlllmercially avaiioble 1\1-J ELISA kit (promcga. Annandale. NSW, Australia). After loading. the beads were then incubated in Ringer's solution at 37'C. and eluants were sampled at regular intervals for up to 5 days 10 examine the n:lcase profile of N'I~3 from the beads.
Three experiments were performed \'arying the a'nount or NT-3 loaded and the number of alginate and alginute·heparin beads. Eaeh experiment varied in the number of beads and the concentration of the load solution as detected in Table l . All elution samples werc tested in triplicate measures to reduce error, The pereenwge of release for each type of beud. in each experiment, was eakulatcd by dividing the quuntity reka<,cd by the ljuuntity of uptake. To increa<,c the power or subsequent slatistil'ul analyses, the results or the three experiments \\erc combined.
In Vivo Experimental Design
The main measure of Olllcomc \\ as the density of SG:-';s surviving after 4 weeks of treatmem (:'\T-3 loaded beads. unloaded beads. and untreat~d controls). SGNs dt:gcllerate. and the majority undergo apoplosi, after the loss of h~ir cells sustained during an ototoxic injury. SmTcssful NT3 delivery was inkrred from an increase in the SG:'\ density ill NT·treated e~rs and compared with untreated ears.
Se·,en-day deafened adult pigmented guinea pigs ranging in \\s:,ight from 650 to l) 109 \VerI' Ilsed for in \ i\() experimetlh, Two methods of delivery of the beads were tested. fUund window and intracochlcar ( Table 2 ). All contr"lateral cochleae w~rc analy/ed as untreUled controls. NT. neurOlrophi,1.
Guinea-Pig Anesthesia
All surgical or auditory brainstem pwcedures were con dueled under anesthesia lIsing an intramuscular injection of l<.damine (60 mg/kg) and xylazine (4 mgfkg). Anesthetic was reversed with antisedan at 0.02 to 0.2 ml/kg. For alginate head implantation procedures, the animals were given a perioperative antibiotic. bay1ril. and an additional analgesic, rimadyl (4 mgfkg). All local skin infiltration wus with 0.3 ml of 2% lignocaine hydmchloride. All procedures and animal care was performed with the approval and guidelines set by the Animal Research and EthKs Committee of the Royal Victorian Eye and Ear Hospital.
Guinea-Pig Auditory Rrainstem Responses and Deafening
Hearing states of all pre-and postrleafened animals were estimated from click-evoked auditory brainstem responses (ABR) (38). Pigmented guinea pigs with a click-evoked ABR threshold of less than 4~ dB peak-equivalent sound pressure level (normal hearing) were deafened by cannulation of the jugular win or its large tributaries and delivery of furosemide (100 mg/kg) followed up by a subeutaneolls injection of kanamycin sulphate (400 rnglkg) to produce a bilateral and symmetrical degeneration of the cochlear sensory epithelnnn (39). A postdeal"ening ABR was performed to conJirm deafness. dctilled bv a click-evoked AfJR threshold of 93 dB peak equivalem' sOllnd pressurc level or llIore. Animals not meeting this criterion were excluded from the study.
Alginate Head Implantation
Seven days afte'r deafening. the guinea pigs were implanted with either small 10:lded (appro\imately 1.5 ~g of NT-3 per bead) or small unloaded bcads, The bulla was approached dorsally and tnc round window visualized under the bony ridge of the facial nen·e. Fur round window implantation. the beads were placed adjaccnt to thc round window (4--5 small beads) and secured Ivilh a muscle/fascial grafl. The scala tympani was implanted by perforating thc round windOlI. passing .. to 5 small beads into the basal tum of the (;ochlc:l. and scaling the round window with a muscle gral"l. Beads were imrlanted for 2H days.
Cochlear Processing and Histology
Guinea pigs were killed with an overdose of sodium pentoharbitone and perfused hy way of the intraeardiac route with O.\J<;i (w/v) saline containing 0.1'70 (v/v) heparin ~odium and 0.015';; (w/v) sodium nitrite followed lip by lO'l, (v/v) neutral buffered fomlalin. The cochleae were removed and postfixed in 10'i( (v/v) neutral buffered formalin for a funher 24 hours, The cochleae werc then decalcified in 4'ii (w/V) ethy1cnediaminctetraacetic acid. For SGN density measure ments, cochleae were cmbedded in paraflin and sectioned at 5 ....111 around the round window and through the mid-modiolar plane. For histologic examination of cochleae around the implantation site. cochleae were embedded in resin and sectioned serially at 125 !-Lm. All sections were stained with hematoxylin-eosin.
Data Analysis
Ali histologic sections were analyzed for inflammatory and fibrotic changes. especially in the vicinity of the implanted beads. SGN densities of individual cochleur turns were counted using Nationallnstilute of Health Scion Image analysis softwarc. Slides Were blinded und randomized before counting. and three mid-modiolar sections were counted and averaged for each cochlea. For each section. SGN densities were analyzed for each modiolar turn.
All the data were entered twice for consistency. Mann Whitney and Kruskal-Wallis nonparametric analysis of vari ance were used to test for differenees in the in vitro NT-3 release stUdy. One-way analysis of variance was used to test for the differences between the three implantation groups (no tremment. round window beads, and intracochlear beads), Ninety-five percent confidence intervals are presented, Mlilti pie comparison tests were also performed to identify which paired treatment was significant. Statistical analysis was performed using SPSS statistical software (V 8.0, Chicago.
IL. U,S.A.). p < 0.05 was considered to be statistically significant.
RESULTS
NT-3 release from alginate heads was cxamined in vitro and measured using ELISA. Three in yitro experiments were performed to e\'aluate the loading and release properties of pillin Hlginate and alginate-heparin beads ( Table I) . NT-3 loading profiles were eYHluated from Experiments 2 and 3. These experiments revealed a high uptake for plain alginate (98.0%) <lnd alginate heparin beads (98.R'k) ( Table 3) .
The release profile is demonstrated in Figure 1 . There was no difference in total amount of release of NT-3 from the plain alginate or heparin-alginate beads oyer a 5-day period (p = 0.95). The "'T-} dctected, expressed as a percentage of initial uptake. over the 5 days was O.3}7( for plain alginate and OJ-Vii-for alginate-heparin beads. However. there was a significant differencc l5etween the two beads in the rele<lse prafik oyer the ~ time period (p = 0.00 I). Plain alginate heads released the majority of the NT-3 in the first 6 hours (94% of the total release over the 5 day period). whereas <lJginate-heparin beads released NT-3 more slowly over the 5 days (Fig. I) . 
Histologic Analysis of Alginate Beads In Vivo
Macroscopic examination of the inner ear al 4 weeks showed that the beads had lost some of their morpho logic shape amI degraded into a gelatinous paste. The round window and basal cochlear turn were analyzed histologically for evidence of local tissLle reaclion to the beads. Hematoxylin-eosin swined sections revealed no significant tissue inflammation or fibrosis. Furthermore, no remnants of the bc.lds were detected; however. this may have been a reSllll of tissue processing.
In Vivo Results of NT·3 Loaded Alginate Beads Spiral ganglion cells of all deafened animals. in cluding those treated with NT-3, e.,hibited ceUs with a range of histopathologic states, from apparently normal to pyknotic cells, some of which lacked nuclei. The criterion for a therapeutic effect of the NT-3 wps an increase in the density or spiral ganglion cells. Only neurons with a clearly defined nucleus were considered to he potentially viable and counted. Mid-modiolar spiral ganglion cell density measurements were made frol11 hoth the round window and the inlracochlcar bead groups. The lknsities from eaeh cochlear turn were measured in triplicate and subsequently averaged. Mid modiolar SON density measurements were averaged across all the mid-modioJar turns of the cochlea, and comparisons were made for each of the individual experimental groups (Table 4) .
In both the round window and intracochlear implan tation sill'S. cochleae treated with alginate beads loaded with NT-3 had greater SON survival than untreated or cochleae implanted with unloaded beads (Fig. 2) . There was no signilicant difference in SON densities between the unloaded and untremed contralateral ears.
In the round window group, a significantly higher SON density difference was observed in the NT-3 loaded beads (p < 0.00 I, mean = 1,060, SD = (20) with the unloaded heads (mean'" 690, SD ::: 180) and untreated cochleas (mean = 770, SD = 190). A significantly higher SGN density difference was also observed in the intracochlear NT-3 loaded bead group (mean'" 980, SD = 210) compared with the unloaded beads (p < 0.00 I, mean =700, SD =250) and untreated cochleas (mean::: 770, SO :: 190) (Fig. 2) .
Effect of Beads on Indh'idual Cochlear Turns Individual cochlear turn auditory nerve density comparisons were made for round window and intra cochlear bead implantations. For both methods of bead delivery, there was significantly higher SON protection in the treated ear through all the cochlear tUIllS (p < 0.00 I); however. there was no differenc<': noted between the turns (Fig. 3) . Although in the intrncochlcar test group there was a trend towurd greater protection in the lower turns. this was not significanl. FtG. 2. Comparison of round window and intracochlear methods 01 bead implantation. Alginate beads loaded either with a control solution (unloaded beads) or with NT-3 (loaded beads) were implanted either onto the round window membrane of deafened guinea pigs or within the basal turn of the cochlea (intraeochlear). NT-3 loaded beads implanted at both sites were eHectlve in maintaining the survival of SGNs compared with unloaded beads or cochleae that received no treatment. Error bars represent standard error of the mean. of 011'-.3. ill the vicinity of 98% 10 99'i(. anu the addition of heparin fa\'(lrably altered thc release kinetics to a slown and steudier release over 5 d::lys (Fig. I ). This (my potentially reduce the toxicity that could be associated with a large initial NT release from alginate. The amount of NT-3 released in vitro (0.337r of initial llptake) was significantly less compared with its uptake. One po,;sihle explanation is that the heads have not yet fully degraded by the end of the relcase study alld that NT-3 is still present within the bead. If so. the potential J'\T-3 deH\'erahle by the bead exceeds that shown from our release studies, and delivery may depend on the rate of degradation in different environments. Anolher possi hie explanation is that NT-3 may be hound to alginate breakdo'Wn produels and not freely available for ELISA Illl'aSUrements. This is suspected because when the head,; were degraded in a calcium-ehelating environ ml:nt of ethylenediamilletetraat'etic aeid to quantify the inilialuplake of I\'T-3, the ffil:asured amount was 0.33'1<-, considerahly less than Ihe 96% anticipated.
The in vivo work has demonstrated the al!!inate hl:parill beads to be an effective delivery vehicle f;r NT 3. with a significant protective effect upon the auditory nerve, The protective effect was measured as an increasl: in the density of surviving spiral ganglion cells. although
the protection was not complete because tre:lted animals had poorer spiral ganglion cell survival than normal controls.
Other protective effects that may be achieved by administration of NTs include an increase in soma size (40) and prcservation or resprouting of peripheral denuritc... (41) . Functional effects of NTs includc a reduction in the thresholu of electrically evoked auuitory brainstelll potentials (42, 43) . Therefore. there may he benefits in delivering NTs to cochlear implant recipients. both in terms of neuronal survival and function. The current study proviues a m(xlel for the development of a clinically applicable delivery method, Although in this study the alginate heads were used in deafened animals. it is anticipated that they may have a role in drug delivery to the hearing ear. Alginate could potentially impact upon hearing by exerting toxic effects lipan the inner ear or alternatively by causing a conduc tive hearing loss when an alginatc bead is placed upon the round window. The latter should be temporary. and resolve when the bead degrades. Further investig:llion is requircu to explore the effects of alginate upon hearing.
This investigation has demonstrated several potentially important advantages of the delivery vehicle. First. alginate-heparin beads are nontoxic to neurons because there was no significant difkrence in SCiN densities hetween cochleae implanted with unloaded bead,; and the untreated ears (Figs. 2 and 3) . Second. the heads are biodegradable. They were found to degraded intu a ge latinous scmiformed paste after 4 week,; in \'ilo. Third, the NT-.3 loaded heads arc efficacious in promoting neuml survival when applied either to the round wlIldow or the basal turn of the cochlea (Figs. 2 and 3 ), This protection was universal for all thc turns of the cochlea (Fig. 3) . Although the protection from the ototoxic insult i was not complete. wilh further refinements of the delivery II system. we may be ahle to a proviue greater degree or :1\ i l release and protection. Such neuronal protection uelll , onstrated by NT-3 loaded alginate-heparin beads coulu I he applied to other areas of nen'e regeneration research such as in the spinal cord and peripheral nerves H-+).
Finally, this preliminary study has demonslrated that round window and intra-coehlear application of algi l1ate-heparin be;lds are equally efficacious in delin:ring NT-3 to the cochlea (h!!s, 2 and 3). The round window -rOllle may have potential clinical applications in de livering: drugs. NTs. and viral vectors in a simple outpatient setting under local anesthesia, Small beads coulu be manufactured. loaded with urugs. anu ueli\ered to the round window by way of a tympanotomy perfom1ed under local anesthesia. Although nol directly applicable in clinical settings. the intracochlear route demonstrated that NT-3 release from a polymer-coated cochlear implant electrode is feasible. This opens up the potential for the delivery of drugs that are impcnneable to the round window or even stem cell deliverv to the cochlea. The current study is the first to den;onstrate efficacious NT delivery bound to a polymer placed adjacent to, or within. the inner ear.
